These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8898337)

  • 41. Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target.
    Yuthavong Y; Tarnchompoo B; Vilaivan T; Chitnumsub P; Kamchonwongpaisan S; Charman SA; McLennan DN; White KL; Vivas L; Bongard E; Thongphanchang C; Taweechai S; Vanichtanankul J; Rattanajak R; Arwon U; Fantauzzi P; Yuvaniyama J; Charman WN; Matthews D
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):16823-8. PubMed ID: 23035243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of new non-pyrimidine scaffolds as
    Hoarau M; Vanichtanankul J; Srimongkolpithak N; Vitsupakorn D; Yuthavong Y; Kamchonwongpaisan S
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):198-206. PubMed ID: 33530764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum.
    Sirawaraporn W; Sirawaraporn R; Cowman AF; Yuthavong Y; Santi DV
    Biochemistry; 1990 Dec; 29(48):10779-85. PubMed ID: 2176883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
    Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
    J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil.
    Vanichtanankul J; Taweechai S; Uttamapinant C; Chitnumsub P; Vilaivan T; Yuthavong Y; Kamchonwongpaisan S
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3928-35. PubMed ID: 22526319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
    Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemical synthesis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene.
    Prapunwattana P; Sirawaraporn W; Yuthavong Y; Santi DV
    Mol Biochem Parasitol; 1996 Dec; 83(1):93-106. PubMed ID: 9010845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
    Fidock DA; Wellems TE
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
    Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
    Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
    J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A biochemical and genetic model for parasite resistance to antifolates. Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum.
    Reynolds MG; Roos DS
    J Biol Chem; 1998 Feb; 273(6):3461-9. PubMed ID: 9452469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Divergent regulation of dihydrofolate reductase between malaria parasite and human host.
    Zhang K; Rathod PK
    Science; 2002 Apr; 296(5567):545-7. PubMed ID: 11964483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transgenic pyrimethamine-resistant plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug.
    Posayapisit N; Pengon J; Prommana P; Shoram M; Yuthavong Y; Uthaipibull C; Kamchonwongpaisan S; Jupatanakul N
    Int J Parasitol; 2021 Jul; 51(8):635-642. PubMed ID: 33713651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli.
    Tahar R; de Pécoulas PE; Basco LK; Chiadmi M; Mazabraud A
    Mol Biochem Parasitol; 2001 Apr; 113(2):241-9. PubMed ID: 11295178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210.
    Ferlan JT; Mookherjee S; Okezie IN; Fulgence L; Sibley CH
    Mol Biochem Parasitol; 2001 Mar; 113(1):139-50. PubMed ID: 11254962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of Plasmodium knowlesi dihydrofolate reductase-thymidylate synthase and sensitivity to antifolates.
    Ittarat W; Pornthanakasem W; Mungthin M; Suwandittakul N; Leelayoova S; Tarnchompoo B; Yuthavong Y; Kongkasuriyachai D; Leartsakulpanich U
    Parasitol Int; 2018 Dec; 67(6):787-792. PubMed ID: 30114522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.
    Wu Y; Kirkman LA; Wellems TE
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1130-4. PubMed ID: 8577727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
    Basco LK; Le Bras J
    Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210.
    Hankins EG; Warhurst DC; Sibley CH
    Mol Biochem Parasitol; 2001 Sep; 117(1):91-102. PubMed ID: 11551635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.